신경외과
  • 의료진소개
  • 홈 > 의료진소개 > 신경외과

  • 목록보기
    박철기  
    의사명 박철기 교수 / 朴哲基 / Park, Chul-Kee
    진료 분야 뇌종양, 경련성뇌종양, 교모세포종, 성상세포종, 핍지교종, 신경교종, 수막종


    >>학력
    기 간 학 력
    2004. 3 ~ 2009. 2 서울대학교 의과대학원 박사
    1999. 3 ~ 2001. 2 서울대학교 의과대학원 석사
    1990. 3 ~ 1996. 2 서울대학교 의과대학, 학사

    >>경력 및 연수
    기 간 경력 및 연수
    2016.09 ~ 현재 서울대학교 의과대학 신경외과학교실 교수
    2014.10 ~ 현재 미국 존스홉킨스 의대 연구교수
    2013.10 ~ 2014.09 미국 존스홉킨스대학병원 방문교수
    2011.09 ~ 2016.08 서울대학교 의과대학 신경외과학교실 부교수
    2006 ~ 2011 서울대학교병원 신경외과 조교수
    2004 ~ 2006 서울대학교병원 신경외과 임상강사
    2001. 3 ~ 2004. 4 군복무
    1997. 3 ~ 2001. 2 서울대학교병원 전공의(신경외과)
    1996. 3 ~ 1997. 2 서울대학교병원 인턴
    1990. 3 ~ 1996. 2 서울대학교 의과대학

    >>학회활동
    기 간 학회활동
    2014 대한 신경외과학회 심보성 학술상
    2012 대한 뇌종양학회 학술상
    2011 아시아신경종양학회 젊은 연구자상
    2008 ~ 현재 미국 암학회 (American Association for Cancer Research) 회원
    2008 대한 신경외과학회 우정현 학술상
    2007 ~ 현재 대한뇌종양학회 정회원
    2007 ~ 현재 American Association of Neurological Surgeons 회원(AANS/CNS Section on Tumors회원)
    2007 대한 뇌종양학회 학술상
    2006 ~ 현재 Society for Neuro-Oncology 회원
    2005 ~ 현재 Congress of Neurological Surgeons 회원
    2004 ~ 현재 대한두개저외과학회 정회원
    2000 ~ 현재 대한신경외과학회 정회원

    >>주요저서
    저서명 출판사명 출판연도 공동저자
    Historical background Prog Neurol Surg. 2012;25:1-12. In. Kim DG, Lunsford LD (eds): Current and Future Management of Brain Metastasis. Prog Neurol Surg. Basel, Karger 2012 Park CK, Kim DG
    중추신경계 종양 종양학 개정판. 일조각. 2012 정희원, 박철기, 김일한
    Parasellar meningioma (Tuberculum sellae meningioma) In. Kalangu Kazadi K.N. (ed): Essential Practice of Neurosurgery. Access Publishing Co. Ltd., Nagoya, Japan 2011 Jung HW, Park CK

    >>주요논문
    논문명 발표지 발표년월 공동연구자
    TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data. Crit Rev Oncol Hematol. 2017 Dec;120:1-9. 2017.12 Vuong HG, Altibi AMA, Duong UNP, Ngo HTT, Pham TQ, Chan AK, Park CK, Fung KM, Hassell L.
    Recursive partitioning analysis for disease progression in adult intracranial ependymoma patients. J Clin Neurosci. 2017 Dec;46:72-78 2017.12 Song SW, Dho YS, Kim JW, Kim YH, Paek SH, Kim DG, Jung HW, Park SH, Choi SH, Kim TM, Lee ST, Kim IH, Lee SH, Park CK.
    BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients. Sci Rep. 2017 Dec 18;7(1):17740 2017.12 Cho HR, Jeon H, Park CK, Park SH, Kang KM, Choi SH.
    Restoration of miR-29b exerts anti-cancer effects on glioblastoma. Cancer Cell Int. 2017 Nov 17;17:104. 2017.11 Shin J, Shim HG, Hwang T, Kim H, Kang SH, Dho YS, Park SH, Kim SJ, Park CK.
    Glutaminase 2 expression is associated with regional heterogeneity of 5-aminolevulinic acid fluorescence in glioblastoma. Sci Rep. 2017 Sep 22;7(1):12221 2017.09 Kim S, Kim JE, Kim YH, Hwang T, Kim SK, Xu WJ, Shin JY, Kim JI, Choi H, Kim HC, Cho HR, Choi A, Chowdhury T, Seo Y, Dho YS, Kim JW, Kim DG, Park SH, Kim H, Choi SH, Park S, Lee SH, Park CK.
    Impact of interim progression during the surgery-to-radiotherapy interval and its predictors in glioblastoma treated with temozolomide-based radiochemotherapy. J Neurooncol. 2017 Aug;134(1):169-175 2017.08 Wee CW, Kim E, Kim TM, Park CK, Kim JW, Choi SH, Yoo RE, Lee ST, Kim IH.
    The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas. Acta Neuropathol Commun. 2017 Aug 29;5(1):62. 2017.08 Lee Y, Koh J, Kim SI, Won JK, Park CK, Choi SH, Park SH.
    A prospective randomized trial of the optimal dose of mannitol for intraoperative brain relaxation in patients undergoing craniotomy for supratentorial brain tumor resection. J Neurosurg. 2017 Jun;126(6):1839-1846. 2017.06 Seo H, Kim E, Jung H, Lim YJ, Kim JW, Park CK, Se YB, Jeon YT, Hwang JW, Park HP.
    Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study. Eur Radiol (2017) 27:3156–3166. 2017.06 Yoo RE, Choi SH, Kim TM, Park CK, Park SH, Won JK, Kim IH, Lee ST, Choi HJ, You SH, Kang KM, Yun TJ, Kim JH, Sohn CH.
    Molecular Testing of Brain Tumor. J Pathol Transl Med. 2017 May;51(3):205-223 2017.05 Park SH, Won J, Kim SI, Lee Y, Park CK, Kim SK, Choi SH.
    An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea, 2013. Brain Tumor Res Treat. 2017 Apr;5(1):16-23. 2017.04 Dho YS, Jung KW, Ha J, Seo Y, Park CK, Won YJ, Yoo H.
    Underexpression of HOXA11 is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma. Cancer Res Treat. 2017 Apr;49(2):387-398 2017.04 Se YB, Kim SH, Kim JY, Kim JE, Dho YS, Kim JW, Kim YH, Woo HG, Kim SH, Kang SH, Kim HJ, Kim TM, Lee ST, Choi SH, Park SH, Kim IH, Kim DG, Park CK.
    Spatiotemporal genomic architecture informs precision oncology in glioblastoma. Nat Genet. 2017 Apr;49(4):594-599. 2017.04 Lee JK, Wang J, Sa JK, Ladewig E, Lee HO, Lee IH, Kang HJ, Rosenbloom DS, Camara PG, Liu Z, Nieuwenhuizen PV, Jung SW, Choi SW, Kim J, Chen A, Kim KT, Shin S, Seo YJ, Oh JM, Shin YJ, Park CK, Kong DS, Seol HJ, Blumberg A, Lee JI, Iavarone A, Park WY, Rabadan R, Nam DH.
    Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status. Radiother Oncol. 2017 Apr;123(1):106-111. 2017.04 Wee CW, Kim E, Kim N, Kim IA, Kim TM, Kim YJ, Park CK, Kim JW, Kim CY, Choi SH, Kim JH, Park SH, Choe G, Lee ST, Chang JH, Kim SH, Suh CO, Kim IH.
    Differentiation between Glioblastoma and Primary Central Nervous System Lymphoma Using Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging: Comparison Study of the Manual versus Semiautomatic Segmentation Method. Investig Magn Reson Imaging. 2017 Mar;21(1):9-19. 2017.03 Kim YE, Choi SH, Lee ST, Kim TM, Park CK, Park SH, Kim IH.
    Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging. Eur Radiol. 2017 Mar;27(3):1176-1185 2017.03 Kim R, Choi SH, Yun TJ, Lee ST, Park CK, Kim TM, Kim JH, Park SW, Sohn CH, Park SH, Kim IH.
    Combined use of susceptibility weighted magnetic resonance imaging sequences and dynamic susceptibility contrast perfusion weighted imaging to improve the accuracy of the differential diagnosis of recurrence and radionecrosis in high- grade glioma patients. Oncotarget. 2017 Mar 21;8(12):20340-20353 2017.03 Kim TH, Yun TJ, Park CK, Kim TM, Kim JH, Sohn CH, Won JK, Park SH, Kim IH, Choi SH.
    A subpopulation of cancer stem cells identifies radiographic characteristics in glioblastoma. Oncol Lett. 2017 Mar;13(3):1175-1182. 2017.03 Kim JE, Kim SK, Shin J, Se YB, Choi SH, Park SH, Choi SA, Lee JY, Phi JH, Wang KC, Park CK, Kim SK.
    A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma. Oncotarget. 2017 Feb 7;8(6):9123-9133. 2017.02 Choi SA, Kwak PA, Park CK, Wang KC, Phi JH, Lee JY, Lee CS, Lee JH, Kim SK.
    Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea. Cancer Res Treat. 2017 Jan;49(1):193-203 2017.01 Kim BS, Seol HJ, Nam DH, Park CK, Kim IH, Kim TM, Kim JH, Cho YH, Yoon SM, Chang JH, Kang SG, Kim EH, Suh CO, Jung TY, Lee KH, Kim CY, Kim IA, Hong CK, Yoo H, Kim JH, Kang SH, Kang MK, Kim EY, Kim SH, Chung DS, Hwang SC, Song JH, Cho SJ, Lee SI, Lee YS, Ahn KJ, Kim SH, Lim DH, Gwak HS, Lee SH, Hong YK.
    Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma. Cancer Res Treat. 2017 Jan;49(1):129-140 2017.01 Cha Y, Kim YJ, Lee SH, Kim TM, Choi SH, Kim DW, Park CK, Kim IH, Kim JH, Kim E, Choi B, Kim CY, Kim IA, Heo DS.
    The survival significance of a measurable enhancing lesion after completing standard treatment for newly diagnosed glioblastoma J Clin Neurosci. 2016 Dec; 34:145-150. 2016.12 Kim SK, Kim TM, Lee ST, Lee SH, Heo DS, Kim IH, Kim DG, Jung HW, Choi SH, Lee SH, Park CK
    Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM Sci Transl Med. 2016 Dec 21;8(370):370ra180 2016.12 Mathios D, Kim JE, Mangraviti A, Phallen J, Park CK, Jackson CM, Garzon-Muvdi T, Kim E, Theodros D, Polanczyk M, Martin AM, Suk I, Ye X, Tyler B, Bettegowda C, Brem H, Pardoll DM, Lim M
    Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging. Oncotarget. 2016 Oct 25;7(43):69606-69615. 2016.11 Cho HR, Hong B, Kim H, Park CK, Park SH, Park S, Choi SH.
    Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR Imaging. PLoS One. 2016 Nov 18;11(11):e0166662 2016.11 Sunwoo L, Yun TJ, You SH, Yoo RE, Kang KM, Choi SH, Kim JH, Sohn CH, Park SW, Jung C, Park CK
    MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction. PLoS One. 2016 Nov 11;11(11):e0166096 2016.11 Kim BR, Choi SH, Yun TJ, Lee ST, Park CK, Kim TM, Kim JH, Park SW, Sohn CH, Park SH, Kim IH.
    Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival. J Korean Med Sci. 2016 Aug;31(8):1208-14. 2016.10 Chaurasia A, Park SH, Seo JW, Park CK
    White Matter Change Revealed by Diffusion Tensor Imaging in Gliomas Brain Tumor Res Treat. 2016 Oct;4(2):100-106 2016.10 Won YI, Chung CK, Kim CH, Park CK, Koo BB, Lee JM, Jung HW
    Application of diffusion-weighted imaging and dynamic susceptibility contrast perfusion-weighted imaging for ganglioglioma in adults: Comparison study with oligodendroglioma J Neuroradiol. 2016 Oct;43(5):331-8. 2016.10 Lee S, Yun TJ, Kang KM, Rhim JH, Park CK, Kim TM, Park SH, Kim IH, Choi SH.
    Gamma Knife Surgery for Recurrent or Residual Supratentorial Primitive Neuroectodermal Tumors Stereotact Funct Neurosurg. 2016 Oct 8;94(4):273-278. 2016.10 Se YB, Kim DG, Kim SK, Kim JW, Kim YH, Park CK, Chung HT, Paek SH
    Dynamic regulation of RNA editing in human brain development and disease Nat Neurosci. 2016 Aug;19(8):1093-9 2016.08 Hwang T, Park CK, Leung AK, Gao Y, Hyde TM, Kleinman JE, Rajpurohit A, Tao R, Shin JH, Weinberger DR
    Predictors of survival for patients with cancer after cryptogenic stroke J Neurooncol. 2016 Jun;128(2):277-84 2016.06 Shin YW, Lee ST, Jung KH, Kim DY, Park CK, Kim TM, Choi SH, Chu K, Lee SK
    Effect of peripheral nerve tetanic stimulation on the inter-trial variability and accuracy of transcranial motor-evoked potential in brain surgery Clinical Neurophysiology. 2016 May;127(5):2208–2213 2016.05 Kim JS, Choi Y, Jin SH, Kim CH, Park CK, Kim SM, Lee KW, Chung CK, Paek SH
    Meningeal Solitary Fibrous Tumors with Delayed Extracranial Metastasis. J Pathol Transl Med. 2016 Mar;50(2):113-21 2016.03 Han N, Kim H, Min SK, Paek SH, Park CK, Choi SH, Chae UR, Park SH.
    Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model Int J Cancer. 2016 Jan 1;138(1):187-94 2016.01 Mathios D, Park CK, Marcus WD, Alter S, Rhode PR, Jeng EK, Wong HC, Pardoll DM, Lim M.
    On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModel PLoS One. 2016 Jan 28;11(1):e0147794 2016.01 Heo H, Kim S, Lee HH, Cho HR, Xu WJ, Lee SH, Park CK, Park S, Choi SH, Kim H
    Genomic dynamics associated with malignant transformation in IDH1 mutated gliomas. Oncotarget. 2015 Dec 22;6(41):43653-66 2015.12 Park CK, Park I, Lee S, Sun CH, Koh Y, Park SH, Kim JE, Yun H, Lee SH
    Application of Volumetric Analysis to Glioblastomas: a Correlation Study on the Status of the Isocitrate Dehydrogenase Mutation Investigative Magnetic Resonance Imaging. 2015 Dec;19(4):218-223 2015.12 Bae SY, Park CK, Kim TM, Park SH, Kim IH, Choi SH
    C-MET overexpression and amplification in gliomas Int J Clin Exp Pathol. 2015 Nov 1;8(11):14932-8.. 2015.11 Kwak Y, Kim SI, Park CK, Paek SH, Lee ST, Park SH
    Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging. Korean J Radiol. 2015 Nov-Dec;16(6):1341-8. 2015.11 Lee EK, Choi SH, Yun TJ, Kang KM, Kim TM, Lee SH, Park CK, Park SH, Kim IH.
    Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging. Neuroradiology. 2015 Nov;57(11):1111-20. 2015.11 Sunwoo L, Choi SH, Yoo RE, Kang KM, Yun TJ, Kim TM, Lee SH, Park CK, Kim JH, Park SW, Sohn CH, Won JK, Park SH, Kim IH
    Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance. PLoS One. 2015 Oct 14;10(10):e0140528 2015.10 Kwon SM, Kang SH, Park CK, Jung S, Park ES, Lee JS, Kim SH, Woo HG.
    A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13-12. J Neurooncol. 2015 Oct;125(1):207-15 2015.10 Kang HC, Yu T, Lim DH, Kim IH, Chung WK, Suh CO, Choi BO, Cho KH, Cho JH, Kim JH, Nam DH, Park CK, Hong YK, Kim IA
    Independent Poor Prognostic Factors for True Progression after Radiation Therapy and Concomitant Temozolomide in Patients with Glioblastoma: Subependymal Enhancement and Low ADC Value. AJNR Am J Neuroradiol. 2015 Oct;36(10):1846-52 2015.10 Yoo RE, Choi SH, Kim TM, Lee SH, Park CK, Park SH, Kim IH, Yun TJ, Kim JH, Sohn CH
    Early cognitive function tests predict early progression in glioblastoma Neuro-Oncology Practice 2015 Sep;2(3):137-143 2015.09 Lee ST, Park CK, Kim JW, Park MJ, Lee H, Lim JA, Choi SH, Kim TM, Lee SH, Park SH, Kim IH, Lee KM
    Spatiotemporal Evolution of the Primary Glioblastoma Genome Cancer Cell. 2015 Sep 14;28(3):318-28 2015.09 Kim J, Lee IH, Cho HJ, Park CK, Jung YS, Kim Y, Nam SH, Kim BS, Johnson MD, Kong DS, Seol HJ, Lee JI, Joo KM, Yoon Y, Park WY, Lee J, Park PJ, Nam DH
    MR Imaging Evaluation of Intracerebral Hemorrhages and T2 Hyperintense White Matter Lesions Appearing after Radiation Therapy in Adult Patients with Primary Brain Tumors. PLoS One. 2015 Aug 31;10(8):e0136795 2015.08 Yoo DH, Song SW, Yun TJ, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Park CK, Kim IH, Choi SH.
    Detection of a Distinctive Genomic Signature in Rhabdoid Glioblastoma, A Rare Disease Entity Identified by Whole Exome Sequencing and Whole Transcriptome Sequencing Transl Oncol. 2015 Aug;8(4):279-287 2015.08 Koh Y, Park I, Sun CH, Lee S, Yun H, Park CK, Park SH, Park JK, Lee SH
    Prognostic implication of progression pattern after anti-VEGF bevacizumab treatment for recurrent malignant gliomas J Neurooncol. 2015 Aug;124(1):101-110. 2015.08 Kim BS, Kim SK, Choi SH, Lee SH, Seol HJ, Nam DH, Lee JI, Park CK, Kong DS
    Mechanism for enhanced 5-aminolevulinic acid fluorescence in isocitrate dehydrogenase 1 mutant malignant gliomas. Oncotarget. 2015 Aug 21;6(24):20266-20277 2015.08 Kim JE, Cho HR, Xu WJ, Kim JY, Kim SK, Kim SK, Park SH, Kim H, Lee SH, Choi SH, Park S, Park CK
    Acute intracranial bleeding and recurrence after bur hole craniotomy for chronic subdural hematoma. J Neurosurg. 2015 Jul;123(1):65-74 2015.07 Pang CH, Lee SE, Kim CH, Kim JE, Kang HS, Park CK, Paek SH, Kim CH, Jahng TA, Kim JW, Kim YH, Kim DG, Chung CK, Jung HW, Yoo H
    Measurement of Apparent Diffusion Coefficient Values from Diffusion-Weighted MRI: A Comparison of Manual and Semiautomatic Segmentation Methods Investigative Magnetic Resonance Imaging. 2015 June;19(2):88-98 2015.06 Kim SH, Choi SH, Yoon TJ, Kim TM, Lee SH, Park CK, Kim JH, Sohn CH, Park SH, Kim IH
    IDH2 mutation in gliomas including novel mutation Neuropathology. 2015 Jun;35(3):236-44 2015.06 Koh J, Cho H, Kim H, Kim SI, Yun S, Park CK, Lee SH, Choi SH, Park SH
    18F-Fluorodeoxyglucose and 11C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas Nucl Med Commun. 2015 Mar;36(3):211-8 2015.03 Choi H, Bang JI, Cheon GJ, Kim YH, Park CK, Park SH, Kang KW, Chung JK, Kim EE, Lee DS
    Glioblastoma Treated with Concurrent Radiation Therapy and Temozolomide Chemotherapy: Differentiation of True Progression from Pseudoprogression with Quantitative Dynamic Contrast-enhanced MR Imaging Radiology. 2015 Mar;274(3):830-40 2015.03 Yun TJ, Park CK, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH, Choi SH
    Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean radiation oncology group study 13-12 J Neurooncol. 2015 Feb;121:531–539 2015.02 Yu T, Kang HC, Lim DH, Kim IH, Chung WK, Suh CO, Choi BO, Cho KH, Cho JH, Kim JH, Park CK, Hong YK, Kim IA
    Hypofractionated chemoradiotherapy with temozolomide as a treatment option for glioblastoma patients with poor prognostic features. Int J Clin Oncol. 2015 Feb;20(1):21-8 2015.02 Lim YJ, Kim IH, Han TJ, Choi SH, Park SH, Park CK, Paek SH, Lee SH, Kim TM
    Metabolomic comparison between cells overexpressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism J Neurochem.2015 Jan;132(2):183-193 2015.01 Wen H, Cho HR, Yun T, Kim H, Park CK, Lee SH, Choi SH, Park S
    Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging J Neurooncol. 2015 Jan;121(1):141-50 2015.01 Lee S, Choi SH, Ryoo I, Yoon TJ, Kim TM, Lee SH, Park CK, Kim JH, Sohn CH, Park SH, Kim IH.
    Central Neurocytoma: Establishment of the Disease Entity Neurosurg Clin N Am. 2015 Jan;26(1):1-4. 2015.01 Kim DG, Park CK
    An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients Int J Cancer. 2015 Jan 1;136(1):162-71 2015.01 An YJ, Cho HR, Kim TM, Keam B, Kim JW, Wen H, Park CK, Lee SH, Im SA, Kim JE, Choi SH, Park S
    Glial Tumors with Neuronal Differentiation Neurosurg Clin N Am. 2015 Jan;26(1):117-138 2015.01 Park CK, Phi JH, Park SH
    Primary diffuse leptomeningeal glioneuronal tumors Brain Tumor Pathol. 2015 Jan;32(1):49-55 2015.01 Cho HJ, Myung JK, Kim H, Park CK, Kim SK, Chung CK, Choi SH, Park SH
    Malignant Glioma: MR Imaging by Using 5-Aminolevulinic Acid in an Animal Model. Radiology 2014 Sep;272(3):720-30 Cho HR, Kim DH, Kim D, Doble P, Bishop D, Hare D, Park CK, Moon WK, Han MH, Choi SH
    Impact of fluorescence-guided surgery on the improvement of clinical outcomes in glioblastoma patients Neuro-Oncology Practice 2014 Sep;1(3):81-85 Kim SK, Choi SH, Kim YH, Park CK
    Extended endoscopic endonasal approach for recurrent or residual adult craniopharyngiomas Acta Neurochir (Wien) 2014 Oct;156(10):1917-22 Kim SK, Kim YH, Park CK, Kim DG, Jung HW
    Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging PLoS One 2014 Nov 24;9(11):e113587 Kim JH, Choi SH, Ryoo I, Yun TJ, Kim TM, Lee SH, Park CK, Kim JH, Sohn CH, Park SH, Kim IH
    Preoperative weakness and demyelination of the corticospinal tract in meningioma patients: changes in diffusion parameters using diffusion tensor imaging J Korean Neurosurg Soc 2014 May;55(5):267-72 Kim MS, Chung CK, Jung HW, Park CK, Kim CH, Kim JS
    HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines Genes Cancer 2014 May;5(5-6):165-74 Kim JW, Kim JY, Kim JE, Kim SK, Chung HT, Park CK
    Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma Oncotarget 2014 May 30;5(10):3399-407 Park CK, Lee SH, Kim JY, Kim JE, Kim TM, Lee ST, Choi SH, Park SH, Kim IH
    Rhabdoid glioblastoma is distinguishable from classical glioblastoma by cytogenetics and molecular genetics Hum Pathol 2014 Mar;45(3):611-20 Byeon SJ, Cho HJ, Baek HW, Park CK, Choi SH, Kim SH, Kim HK, Park SH
    Glioma: Application of Histogram Analysis of Pharmacokinetic Parameters from T1-Weighted Dynamic Contrast-Enhanced MR Imaging to Tumor Grading AJNR Am J Neuroradiol 2014 Jun;35(6):1103-10 Jung SC, Yeom JA, Kim JH, Ryoo I, Kim SC, Shin H, Lee AL, Yun TJ, Park CK, Sohn CH, Park SH, Choi SH
    Differentiation of True Recurrence from Delayed Radiation Therapy-related Changes in Primary Brain Tumors Using Diffusion-weighted Imaging, Dynamic Susceptibility Contrast Perfusion Imaging, and Susceptibility-weighted Imaging J Korean Soc Magn Reson Med 2014 Jun;18(2):120-132 Kim DH, Choi SH, Ryoo I, Yoon TJ, Kim TM, Lee SH, Park CK, Kim JH, Sohn CH, Park SH, Kim IH
    Low-Dose Whole Brain Radiotherapy with Tumor Bed Boost after Methotrexate-Based Chemotherapy for Primary Central Nervous System Lymphoma Cancer Res Treat 2014 Jul;46(3):261-269 Kim BH, Kim IH, Park SH, Park CK, Jung HW, Kim TM, Lee SH, Heo DS
    Correlation of 11C-methionine PET and diffusion-weighted MRI: is there a complementary diagnostic role for gliomas? Nucl Med Commun 2014 Jul;35(7):720-6 Choi H, Paeng JC, Cheon GJ, Park CK, Choi SH, Min HS, Kang KW, Chung JK, Kim EE, Lee DS
    Toxicity profile of temozolomide in the treatment of 300 malignant glioma patients in Korea J Korean Med Sci 2014 Jul;29(7):980-4 Bae SH, Park MJ, Lee MM, Kim TM, Lee SH, Cho SY, Kim YH, Kim YJ, Park CK, Kim CY
    Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase Eur J Cancer 2014 Jan;50(1):137-49 Choi SA, Lee JY, Phi JH, Wang KC, Park CK, Park SH, Kim SK
    Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures J Neurooncol 2014 Jan;116(1):49-57 Lee JY, Lee DH, Kim HA, Choi SA, Lee HJ, Park CK, Phi JH, Wang KC, Kim SU, Kim SK
    Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status Transl Oncol 2014 Dec;7(6):712-9 Myung JK, Cho HJ, Kim H, Park CK, Lee SH, Choi SH, Park P, Yoon JM, Park SH
    5-Aminolevulinic acid fluorescence discriminates the histological grade of extraventricular neurocytoma Brain Tumor Res Treat 2013;1:45-49 Song SW, Kim YH, Park SH, Park CK
    Tumor blood flow from arterial spin labeling perfusion MRI: a key parameter in distinguishing high-grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high-grade gliomas. J Magn Reson Imaging 2013 Oct;38(4):852-60 Yoo RE, Choi SH, Cho HR, Kim TM, Lee SH, Park CK, Park SH, Kim IH, Yun TJ, Kim JH, Sohn CH, Han MH, Chang KH
    Stereotactic radiosurgery for brain metastases from hepatocellular carcinoma J Neurooncol 2013 Oct;115(1):45-51 Han JH, Kim DG, Chung HT, Paek SH, Park CK, Kim CY, Kim YH, Jung HW
    The role of adjuvant radiotherapy in atypical meningioma J Neurooncol 2013 Nov;115(2):241-7 Park HJ, Kang HC, Kim IH, Park SH, Kim DG, Park CK, Paek SH, Jung HW
    Seizures during the management of high-grade gliomas: clinical relevance to disease progression J Neurooncol 2013 May;113(1):101-9 Kim YH, Park CK, Kim TM, Choi SH, Kim YJ, Choi BS, Han JH, Lee SH, Kim CY, Kim IA, Heo DS, Kim IH, Kim DG, Jung HW
    Early response evaluation for recurrent high grade gliomas treated with bevacizumab: a volumetric analysis using diffusion-weighted imaging J Neurooncol 2013 May;112(3):427-35 Hwang EJ, Cha Y, Lee AL, Yun TJ, Kim TM, Park CK, Kim JH, Sohn CH, Park SH, Kim IH, Heo DS, Lee SH, Choi SH
    Gliomas: Application of Cumulative Histogram Analysis of Normalized Cerebral Blood Volume on 3 T MRI to Tumor Grading PLoS One 2013 May 21;8(5):e63462 Kim H, Choi SH, Kim JH, Ryoo I, Kim SC, Yeom JA, Shin H, Jung SC, Lee AL, Yun TJ, Park CK, Sohn CH, Park SH
    Central Neurocytoma: Long-term Outcomes of Multimodal Treatments and Management Strategies Based on 30 Years' Experience in a Single Institute Neurosurgery 2013 Mar;72(3):407-14 Kim JW, Kim DG, Kim IK, Kim YH, Choi SH, Han JH, Park CK, Chung HT, Park SH, Paek SH, Jung HW
    The role of surgical resection in the management of brain metastasis: a 17-year longitudinal study Acta Neurochir (Wien). 2013 Mar;155(3):389-97 Lee CH, Kim DG, Kim JW, Han JH, Kim YH, Park CK, Kim CY, Paek SH, Jung HW.
    True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis Korean J Radiol 2013 Jul-Aug;14(4):662-72 Song YS, Choi SH, Park CK, Yi KS, Lee WJ, Yun TJ, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH, Jahng GH, Chang KH
    Hearing Outcomes After Stereotactic Radiosurgery for Unilateral Intracanalicular Vestibular Schwannomas: Implication of Transient Volume Expansion Int J Radiat Oncol Biol Phys 2013 Jan 1;85(1):61-7 Kim YH, Kim DG, Ho Han J, Chung HT, Kim IK, Song SW, Park JH, Kim JW, Kim YH, Park CK, Kim CY, Paek SH, Jung HW
    Tumor blood flow from arterial spin labeling perfusion MRI: A key parameter in distinguishing high-grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high-grade gliomas J Magn Reson Imaging 2013 Feb;37(2):351-8 Yoo RE, Choi SH, Cho HR, Kim TM, Lee SH, Park CK, Park SH, Kim IH, Yun TJ, Kim JH, Sohn CH, Han MH, Chang KH
    Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme J Magn Reson Imaging 2013 Feb;37(2):351-8 Sunwoo L, Choi SH, Park CK, Kim JW, Yi KS, Lee WJ, Yoon TJ, Song SW, Kim JE, Kim JY, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH, Chang KH
    The enigma of bifocal germ cell tumors in the suprasellar and pineal regions: synchronous lesions or metastasis? J Neurosurg Pediatr 2013 Feb;11(2):107-14 Phi JH, Kim SK, Lee J, Park CK, Kim IH, Ahn HS, Shin HY, Kim IO, Jung HW, Kim DG, Paek SH, Wang KC
    Temozolomide salvage chemotherapy for recurrent anaplastic oligodendroglioma and oligo-astrocytoma J Korean Neurosurg Soc 2013 Dec;54(6):489-95 Gwak HS, Yee GT, Park CK, Kim JW, Hong YK, Kang SG, Kim JH, Seol HJ, Jung TY, Chang JH, Yoo H, Hwang JH, Kim SH, Park BJ, Hwang SC, Kim MS, Kim SH, Kim EY, Kim E, Kim HY, Ko YC, Yun HJ, Youn JH, Kim J, Lee B, Lee SH
    Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging Radiology 2013 Dec;269(3):831-40 Chu HH, Choi SH, Ryoo I, Kim SC, Yeom JA, Shin H, Jung SC, Lee AL, Yoon TJ, Kim TM, Lee SH, Park CK, Kim JH, Sohn CH, Park SH, Kim IH.
    Radiosurgery for central neurocytoma: long-term outcome and failure pattern J Neurooncol 2013 Dec;115(3):505-11 Kim JW, Kim DG, Chung HT, Choi SH, Han JH, Park CK, Kim CY, Paek SH, Jung HW
    A highly facile and specific assay for cancer-causing isocitrate dehydrogenase mutant using 13C4-labeled α-ketoglutarate and heteronuclear NMR Anal Chem 2013 Dec 17;85(24):11987-92 Wen H, Yun T, Xu WJ, Choi SH, Kim H, Park CK, Lee SH, Park SW, Lee SK, Park S.
    A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma Neuro Oncol 2013 Aug;15(8):1096-101 Park CK, Kim JH, Nam DH, Kim CY, Chung SB, Kim YH, Seol HJ, Kim TM, Choi SH, Lee SH, Heo DS, Kim IH, Kim DG, Jung HW
    Cerebral Blood Volume Analysis in Glioblastomas Using Dynamic Susceptibility Contrast-Enhanced Perfusion MRI: A Comparison of Manual and Semiautomatic Segmentation Methods. PLoS One 2013 Aug 8;8(8):e69323 Jung SC, Choi SH, Yeom JA, Kim JH, Ryoo I, Kim SC, Shin H, Lee AL, Yun TJ, Park CK, Sohn CH, Park SH
    Cerebral blood volume calculated by dynamic susceptibility contrast-enhanced perfusion MR imaging: preliminary correlation study with glioblastoma genetic profiles PLoS One 2013 Aug 19;8(8):e71704 Ryoo I, Choi SH, Kim JH, Sohn CH, Kim SC, Shin HS, Yeom JA, Jung SC, Lee AL, Yun TJ, Park CK, Park SH
    Clinicopathological and genetic characteristics of extraventricular neurocytomas Neuropathology 2013 Apr;33(2):111-21 Myung JK, Cho HJ, Park CK, Chung CK, Choi SH, Kim SK, Park SH
    Alpha internexin expression related with molecular characteristics in adult glioblastoma and oligodendroglioma J Korean Med Sci 2013 Apr;28(4):593-601 Suh JH, Park CK, Park SH
    The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma J Neurooncol 2013 Apr;112(2):277-83 Park CK, Lee SH, Kim TM, Choi SH, Park SH, Heo DS, Kim IH, Jung HW
    Longitudinal Analysis of Visual Outcomes After Surgical Treatment of Adult Craniopharyngiomas Neurosurgery. 2012 Sep;71(3):715-21 Kim YH, Kim CY, Kim JW, Kim YH, Han JH, Park CK, Paek SH, Oh CW, Kim DG, Jung HW
    The Changes in MGMT Promoter Methylation Status in Initial and Recurrent Glioblastomas Transl Oncol 2012 Oct;5(5):393-7 Park CK, Kim JE, Kim JY, Song SW, Kim JW, Choi SH, Kim TM, Lee SH, Kim IH, Park SH
    Intracranial intradural chordoma presenting with intraventricular hemorrhage Clin Neurol Neurosurg. 2012 Oct;114(8):1189-92 Kim SK, Kim YH, Park CK, Kim MA, Park SH
    IDH1 mutation of gliomas with long-term survival analysis Oncol Rep 2012 Nov;28(5):1639-44 Myung JK, Cho HJ, Park CK, Kim SK, Phi JH, Park SH
    Diffusion-weighted MR Imaging for the Differentiation of True Progression from Pseudoprogression following Concomitant Radiotherapy with Temozolomide in Patients with Newly Diagnosed High-grade Gliomas Acad Radiol 2012 Nov;19(11):1353-61 Lee WJ, Choi SH, Park CK, Yi KS, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH
    MR imaging findings of extraventricular neurocytoma: a series of ten patients confirmed by immunohistochemistry of IDH1 gene mutation Acta Neurochir (Wien) 2012 Nov;154(11):1973-80 Yi KS, Sohn CH, Yun TJ, Choi SH, Kim JH, Han MH, Park CK, Park SH, Chang KH
    A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells Cancer Lett. 2012 Nov 28;324(2):221-30 Choi SA, Wang KC, Phi JH, Lee JY, Park CK, Park SH, Kim SK
    Radiosurgery for Para-IAC Meningiomas: The Effect of Radiation Dose to the Cochlea on Hearing Outcome Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):675-80 Kim YH, Kim DG, Han JH, Chung HT, Kim IK, Song SW, Park JH, Kim JW, Kim YH, Park CK, Kim CY, Paek SH, Jung HW
    Hearing preservation in patients with unilateral vestibular schwannoma who undergo stereotactic radiosurgery: Reinterpretation of the auditory brainstem response Cancer 2012 Nov 1;118(21):5441-7 Han JH, Kim DG, Chung HT, Paek SH, Park CK, Kim CY, Kim YH, Kim JW, Kim YH, Song SW, Kim IK, Jung HW
    The Risk Factors of Symptomatic Communicating Hydrocephalus After Stereotactic Radiosurgery for Unilateral Vestibular Schwannoma: The Implication of Brain Atrophy Int J Radiat Oncol Biol Phys 2012 Nov 15;84(4):937-42 Han JH, Kim DG, Chung HT, Paek SH, Park CK, Kim CY, Hwang SS, Park JH, Kim YH, Kim JW, Kim YH, Song SW, Kim IK, Jung HW
    Radiosurgery for Large Brain Metastases Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):113-20 Han JH, Kim DG, Chung HT, Paek SH, Park CK, Jung HW
    Cognitive Function of Korean Neurosurgical Patients: Cross-sectional Study Using the Korean Version of the Mini-mental Status Examination J Cerebrovasc Endovasc Neurosurg. 2012 Mar;14(1):11-21 Kim J, Kim CH, Kang HS, Park CK, Chung CK
    Radiosurgery for Atypical and Anaplastic Meningiomas: Histopathological Predictors of Local Tumor Control Stereotact Funct Neurosurg. 2012 Jul 12;90(5):316-324 Kim JW, Kim DG, Paek SH, Chung HT, Myung JK, Park SH, Kim YH, Han JH, Yang SY, Park CK, Jung HW
    Antitumor activity of CKD-602, a camptothecin derivative, in a mouse glioma model J Clin Neurosci. 2012 Feb;19(2):301-5 Kim CY, Lee SJ, Kim SK, Park CK, Wang KC, Cho BK
    Experience with 5-aminolevulinic acid in fluorescence-guided resection of a deep sylvian meningioma J Korean Neurosurg Soc 2012 Dec;52(6):558-560 Chae MP, Song SW, Park SH, Park CK
    Analysis of the BRAF(V600E) Mutation in Central Nervous System Tumors Transl Oncol 2012 Dec;5(6):430-6 Myung JK, Cho H, Park CK, Kim SK, Lee SH, Park SH
    The role of chemotherapy in anaplastic astrocytoma patients J Korean Neurosurg Soc. 2012 Apr;51(4):199-202 Kim SK, Kim JW, Kim YH, Kim TM, Lee SH, Park CK
    Early Significant Tumor Volume Reduction After Radiosurgery in Brain Metastases from Renal Cell Carcinoma Results in Long-Term Survival Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1749-55 Kim WH, Kim DG, Han JH, Paek SH, Chung HT, Park CK, Kim CY, Kim YH, Kim JW, Jung HW
    Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours J Neurol Neurosurg Psychiatry 2011;82(2):224-7 Kim JW, Park CK, Park SH, Kim YH, Han JH, Kim CY, Sohn CH, Chang KH, Jung HW
    Cerebrospinal fluid M staging for medulloblastoma: Reappraisal of Chang's M staging based on the CSF flow Neuro Oncol 2011;13(3):334-44 Phi JH, Lee J, Wang KC, Cho BK, Kim IO, Park CK, Kim CY, Ahn HS, Kim IH, Kim SK
    Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients Neuro Oncol 2011;13(2):195-202 Park CK, Kim J, Yim SY, Lee AR, Han JH, Kim CY, Park SH, Kim TM, Lee SH, Choi SH, Kim SK, Kim DG, Jung HW
    Hemangioblastoma J Neurosurg 2011;114(3):886-7 Park CK
    Let-7 microRNA inhibits the proliferation of human glioblastoma cells J Neurooncol 2011;102(1):19-24 Lee ST, Chu K, Oh HJ, Im WS, Lim JY, Kim SK, Park CK, Jung KH, Lee SK, Kim M, Roh JK
    O(6)-methylguanine DNA methyltransferase status determined by promoter methylation and immunohistochemistry in gliosarcoma and their clinical implications J Neurooncol 2011;101(3):477-86 Kang SH, Park KJ, Kim CY, Yu MO, Park CK, Park SH, Chung YG
    An endoscopic endonsal transethmoidal approach to olfactory groove meningioma Cen Eur Neurosurg 2011 Nov;72(4):205-8 Kim YH, Han DH, Park CK, Lee CH, Kim DG
    MGMT promoter gene methylation in pediatric glioblastoma: analysis using MS-MLPA Childs Nerv Syst 2011 Nov;27(11):1877-83 Lee JY, Park CK, Park SH, Wang KC, Cho BK, Kim SK
    Great hospitals of Asia: the department of neurosurgery at seoul national university college of medicine World Neurosurg 2011 Mar-Apr;75(3-4):397-406 Kim DG, Park CK, Paek SH, Kim JE, Kim CH, Phi JH
    Great hospitals of Asia: the department of neurosurgery at seoul national university college of medicine World Neurosurg 2011 Mar-Apr;75(3-4):397-406 Kim DG, Park CK, Paek SH, Kim JE, Kim CH, Phi JH
    Cavernous malformation of the cisternal trigeminal nerve Br J Neurosurg 2011 Jun;25(3):339-40 Cho WS, Kang HS, Kim JW, Park CK, Kim JE
    Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial J Neurooncol 2011 Jul;103(3):595-602 Kim IH, Park CK, Heo DS, Kim CY, Rhee CH, Nam DH, Lee SH, Han JH, Lee SH, Kim TM, Kim DW, Kim JE, Paek SH, Kim DG, Kim IA, Kim YJ, Kim JH, Park BJ, Jung HW
    Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study J Neurooncol 2011 Jul;103(3):503-12 Kim YH, Park CK, Cho WH, Kim IA, Moon S, Choe G, Park SH, Kim IH, Kim DG, Jung HW, Lee MM, Bae SH, Cha SH, Kim CY
    Surgically treated brain tumors: a retrospective case series of 10,009 cases at a single institution World Neurosurg 2011 Dec;76(6):555-63 Kim YH, Song SW, Lee JY, Kim JW, Kim YH, Phi JH, Park CK, Kim JE, Kim SK, Paek SH, Chung CK, Wang KC, Kim DG, Jung HW
    Papillary Glioneuronal Tumors: A Review of Clinicopathologic and Molecular Genetic Studies Am J Surg Pathol 2011 Dec;35(12):1794-805 Myung JK, Byeon SJ, Kim B, Suh J, Kim SK, Park CK, Chung CK, Chang KH, Park SH
    Gamma Knife stereotactic radiosurgery for intracranial hemangiopericytomas J Neurooncol 2010;99(1):115-122 Kim JW, Kim DG, Chung HT, Paek SH, Kim YH, Han JH, Park CK, Kim CY, Jung HW
    Efficacy of Corticosteroids in Hearing Preservation after Radiosurgery for Vestibular Schwannoma: A Prospective Study Stereotact Funct Neurosurg 2010;89(1):25-33 Kim JW, Kim DG, Paek SH, Chung HT, Kim YH, Han JH, Park CK, Jung HW
    Protective role of COMP-Ang1 in ischemic rat brain J Neurosci Res 2010;88(5):1052-63 Shin HY, Lee YJ, Kim HJ, Park CK, Kim JH, Wang KC, Kim DG, Koh GY, Paek SH
    Papillary tumor of pineal region presenting with leptomeningeal seeding Neuropathology 2010;30(6):654-60 Kim YH, Kim JW, Park CK, Kim DG, Sohn CH, Chang KH, Park SH
    Molecular Characterization of the NF2 Gene in Korean Patients with Neurofibromatosis Type 2: A Report of Four Novel Mutations Korean J Lab Med 2010;30(2):190-4 Seong MW, Yeo IK, Cho SI, Park CK, Kim SK, Paek SH, Kim DG, Jung HW, Park H, Kim SY, Kim JY, Park SS
    Radiosurgery for brain metastasis from advanced gastric cancer Acta Neurochir (Wien) 2010;152(4):605-10. Epub 2009 Han JH, Kim DG, Chung HT, Kim CY, Park CK, Chung YS, Paek SH, Yoo MW, Kim BH, Jung HW
    Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: Assessing the efficacy of (18)F-FDG PET, (11)C-methionine PET and perfusion MRI Clin Neurol Neurosurg 2010;112(9):758-65 Kim YH, Oh SW, Lim YJ, Park CK, Lee SH, Kang KW, Jung HW, Chang KH
    Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study J Neurooncol 2010 Sep 24 Kim YH, Park CK, Cho WH, Kim IA, Moon S, Choe G, Park SH, Kim IH, Kim DG, Jung HW, Lee MM, Bae SH, Cha SH, Kim CY.
    Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial J Neurooncol 2010 Nov 4 Kim IH, Park CK, Heo DS, Kim CY, Rhee CH, Nam DH, Lee SH, Han JH, Lee SH, Kim TM, Kim DW, Kim JE, Paek SH, Kim DG, Kim IA, Kim YJ, Kim JH, Park BJ, Jung HW
    The clinicopathologic values of the molecules associated with the main pathogenesis of the glioblastoma J Neurol Sci 2010 Jul 15;294(1-2):112-8 Kim B, Myung JK, Seo JH, Park CK, Paek SH, Kim DG, Jung HW, Park SH
    Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy BMC Cancer 2009;9:450 Park CK, Lee SH, Han JH, Kim CY, Kim DW, Paek SH, Kim DG, Heo DS, Kim IH, Jung HW
    Multifarious proteomic signatures and regional heterogeneity in glioblastomas. J Neurooncol 2009;94(1):31-9 Park CK, Jung JH, Park SH, Jung HW, Cho BK
    Tissue expression of manganese superoxide dismutase is a candidate prognostic marker for glioblastoma. Oncology 2009;77(3-4):178-181 Park CK, Jung JH, Moon MJ, Kim YY, Kim JH, Park SH, Kim CY, Paek SH, Kim DG, Jung HW, Cho BK
    Fatal fluctuation of serum potassium level during barbiturate coma therapy. J Kor Neurotraumatol Soc 2009;5:131-134 Sohn S, Park CK
    Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: a retrospective analysis. Chemotherapy 2009;55(3):145-54 Han JH, Park CK, Lee SH, Kim CY, Kim DW, Paek SH, Kim DG, Heo DS, Kim IH, Jung HW
    Methylation satus of the O6-mthylguanine-doxyribonucleic acid methyltransferase gene promoter in World Health Organization Grade III gliomas J Korean Neurosurg Soc 2009;46:385-388 Yang SH, Kim YH, Kim JW, Park CK, Park SH, Jung HW
    Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin. Neuropathology 2009;29(4):443-9 Park CK, Park SH, Lee SH, Kim CY, Kim DW, Paek SH, Kim DG, Heo DS, Kim IH, Jung HW
    CKD-602, a camptothecin derivative, inhibits proliferation and induces apoptosis in glioma cell lines. Oncol Rep 2009;21(6):1413-9 Kim YY, Park CK, Kim SK, Phi JH, Kim JH, Kim CY, Wang KC, Cho BK
    Long-term outcome of conventional radiation therapy for central neurocytoma. J Neurooncol 2008;90(1):25-30 Paek SH, Han JH, Kim JW, Park CK, Jung HW, Park SH, Kim IH, Kim DG
    Endogenous neurogenesis and neovascularization in the neocortex of the rat after focal cerebral ischemia. J Neurosci Res 2008;86(2):356-67 Shin HY, Kim JH, Phi JH, Park CK, Kim JE, Kim JH, Paek SH, Wang KC, Kim DG
    Atypical and anaplastic meningiomas: prognostic implication of clinicopathological features J Neurol Neurosurg Psychiatry 2008;79(5):574-80 Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW
    Gamma Knife Radiosurgery for Skull Base Meningiomas: Long-Term Radiologic and Clinical Outcome. Int J Radiat Oncol Biol Phys 2008;72(5):1324-32 Han JH, Kim DG, Chung HT, Park CK, Paek SH, Kim CY, Jung HW
    Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway Am J Surg Pathol 2008;32(1):103-112 Phi JH, Park SH, Kim SK, Paek SH, Kim JH, Lee YJ, Cho BK, Park CK, Lee DH, Wang KC
    Primary CNS lymphoma presenting with acute blindness and encephalocele J Clin Oncol 2008;26(4):678-9 Huh W, Han JH, Park CK, Park SH
    Treatment of cavernous sinus meningioma: long-term outcome and lessons learned J Korean Skull Base Soc 2008;1:31-37 Lee SJ, Han JH, Park CK, Kim CY, Paek SH, Kim DG, Jung HW
    Investigation of molecular factors associated with malignant transformation of oligodendroglioma by proteomic study of a single case of rapid tumor progression J Cancer Res Clin Oncol 2008;134(2):255-62 Park CK, Kim JH, Moon MJ, Jung JH, Lim SY, Park SH, Kim JH, Kim DG, Jung HW, Cho BK, Paek SH
    Time- dependent changes of the infarct volume in a rat stroke model: a comparison of the use of MRI and TTC- staining as monitoring tools Kor J Cerebrovascular Surgery 2008;10:437-441 Kwon JW, Park CK, Shin HY, Paek SH, Wang KC, Kim DG
    Clinical and neuroimaging outcome of cerebral arteriovenous malformations after Gamma Knife surgery: analysis of the radiation injury rate depending on the arteriovenous malformation volume J Neurosurg 2008;109(2):191-8 Han JH, Kim DG, Chung HT, Park CK, Paek SH, Kim JE, Jung HW, Han DH
    Gamma Knife surgery for brain metastasis from renal cell carcinoma: relationship between radiological characteristics and initial tumor response J Korean Neurosurg Soc 2007;42:92-96 Kim JW, Han JH, Park CK, Chung HT, Paek SH, Kim DG
    Long-term outcomes of gamma knife stereotactic Radiosurgery of vestibular schwannomas J Korean Neurosurg Soc 2007;42:286-292 Kim KM, Park CK, Chung HT, Paek SH, Jung HW, Kim DG
    Falx meningiomas: surgical results and lessons learned from 68 cases J Korean Neurosurg Soc 2007;42:276-280 Chung SB, Kim CY, Park CK, Kim DG, Jung HW
    A case of basal ganglia meningioma J Korean Skull Base Soc 2007;2:40-43 Kim JW, Park CK, Han JH, Jung HW
    Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization Neuropathology 2007;27:10-20 Jeon YK, Park K, Park CK, Paek SH, Jung HW, Park SH
    Expression of Sox2 in mature and immature teratomas of central nervous system Mod Pathol 2007;20(7):742-8 Phi JH, Park SH, Paek SH, Kim SK, Lee YJ, Park CK, Cho BK, Lee DH, Wang KC
    Malignant Triton tumour mistaken for pituitary adenoma Acta Neurochir (Wien) 2007;149(12):1265-7 Kim KM, Park CK, Park SH, Paek SH, Kim DG, Jung HW
    Simple measurement of spinal cord evoked potential: A valuable data source in the rat spinal cord injury model J Clin Neurosci 2007;14(11):1099-105 Park JP, Kim KJ, Phi JH, Park CK, Kim JH, Kang HJ, Lee D, Han KH, Wang KC, Paek SH.
    Gamma knife radiosurgery for central neurocytoma: primary and secondary treatment Cancer 2007;110(10):2276-84 Kim CY, Paek SH, Jeong SS, Chung HT, Han JH, Park CK, Jung HW, Kim DG
    Gamma Knife surgery and trigeminal schwannoma: is it possible to preserve cranial nerve function? J Neurosurg 2007;107:727-732 Phi JH, Paek SH, Chung HT, Jeong SS, Park CK, Jung HW, Kim DG
    Therapeutic Strategy for Large Vestibular Schwannomas J Neurooncol 2006;77(2):167-171 Park CK, Jung HW, Kim JE, Son YJ, Paek SH, Kim DG
    The Selection of the Optimal Therapeutic Strategy for Petroclival Meningiomas Surg Neurol 2006;66(2):160-165 Park CK, Jung HW, Kim JE, Paek SH, Kim DG
    Surgically Treated Tuberculum Sellae and Diaphragm Sellae Meningiomas: The Importance of Short-term Visual Outcome Neurosurgery 2006;59(2):238-243 Park CK, Jung HW, Yang SY, Seol HJ, Paek SH, Kim DG
    Optimal Extent of Resection in Vestibular Schwannoma Surgery: Relationship to Recurrence and Facial Nerve Preservation Neurol Med Chir (Tokyo) 2006;46(4):176-181 Seol HJ, Kim CH, Park CK, Kim CH, Kim DG, Chung YS, Jung HW
    Postoperative Brain Swelling after Resection of Olfactory Groove Meningiomas J Korean Neurosurg Soc 2006;40:423-427 Song SW, Park CK, Paek SH, Kim DG, Jung HW, Chung YS
    Gamma Knife Surgery for the Pineal Region Tumors J Korean Neurosurg Soc 2006;40:342-345 Cho SY, Park CK, Chung HT, Paek SH, Kim DG
    What Do You Think about the Journal of Korean Neurosurgical Society? : Survey of Korean Neurosurgical Society Members J Korean Neurosurg Soc 2006;40:309-313 Park CK, Yi MA,Yang HJ, Chung HT, Kim DG
    Korean Medical Citation Index(KoMCI) and Journal of Korean Neurosurgical Society J Korean Neurosurg Soc 2006;40:300-303 Yang HJ, Chung HT, Park CK, Yi MA, Kim DG
    Anatomical considerations in Gamma Knife radiosurgery for idiopathic trigeminal neuralgia J Korean Neurosurg Soc 2006;40:148-153 Kim YH, Park CK, Chung HT, Paek SH, Kim DG
    Management of Recurrent Vestibular Schwannomas J Korean Neurosurg Soc 2006;39:87-91 Kim WH, Park CK, Kim DG, Jung HW
    Brain Metastasis from Dermatofibrosarcoma Protuberans: A Case Report J Korean Neurosurg Soc 2006;39:148-151 Kim WH, Park CK, Kim DG, Jung HW
    Surgical outcome and prognostic factors of pediatric epilepsy caused by cortical dysplasia Childs Nerv Syst 2006;22(6):586-592 Park CK, Kim SK, Wang KC, Hwang YS, Kim KJ, Chae JH, Chi JG, Choe GY, Kim NR, Cho BK
    Recurrent juvenile nasopharyngeal angiofibroma treated with Gamma Knife Surgery J Korean Med Sci 2006;21(4):773-777 Park CK, Kim DG, Paek SH, Chung HT, Jung HW
    The role of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in microcystic meningiomas Oncol Rep 2006;16(1):49-56 Paek SH, Kim DG, Park CK, Phi JH, Kim YY, Im SY, Kim JE, Park SH, Jung HW
    Microhemorrhage, a possible mechanism for cyst formation in vestibular schwannomas J Neurosurg 2006;105:576-580 Park CK, Kim DC, Park SH, Kim JE, Paek SH, Kim DG, Jung HW
    Bo Sung Sim (1924?2001): a pioneer of neurosurgery in Korea J Neurosurg 2006;105:494-497 Kim DG, Park CK, Paek SH
    Microcystic meningiomas: radiological characteristics of 16 cases Acta Neurochir (Wien) 2005;147(9):965-972 Paek SH, Kim SH, Chang KH, Park CK, Kim JE, Kim DG, Park SH, Jung HW
    Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma Cancer 2005;104(3):580-590 Paek SH, Chung HT, Jeong SS, Park CK, Kim CY, Kim JE, Kim DG, Jung HW
    Prevalence and clinical characteristics of intervertebral disc herniation in adolescence: a study based on examinations for conscription Korean J Spine 2004;1:83-87 Hong CK, Park CK, Park HC, Yoon SH
    Intracerebral Hemorrhage After γ-Knife Surgery for Metastatic Brain Tumor Journal of Radiosurgery 2000;3(1):17-20 Park CK, Kim DG, Gwak HS, Chung HT, Paek SH
    Treatment Outcome and Prognostic Factors of Cushing's Disease in Adults J Korean Neurosurg Soc 2000;29:1316-1321 Park CK, Hwang SK, Gwak HS, Yoo H, Chung YS, Paek SH, Kim DG, Jung HW, Kim SY, Hong SK
    Transoral protrusion of a peritoneal catheter: a case report and literature review Childs Nerv Syst 2000;16(3):184-189 Park CK, Wang KC, Seo JK, Cho BK
    Intramedullary spinal cord ganglioglioma: a report of five cases Acta Neurochir (Wien) 2000;142(5):547-552 Park CK, Chung CK, Choe GY, Wang KC, Cho BK, Kim HJ
    Meningioma manifesting intracerebral haemorrhage: a possible mechanism of haemorrhage Acta Neurochir (Wien) 2000;142(2):165-168 Kim DG, Park CK, Paek SH, Choe GY, Gwak HS, Yoo H, Jung HW